Wells Score for Pulmonary Embolism
Pre-test probability assessment for suspected acute pulmonary embolism. Drives the D-dimer vs CTPA decision per ESC 2019, ACEP, and AIIMS Emergency Medicine protocols.
Wells Score
0
PE Unlikely • ~12% PE prevalence
Next Step
Obtain age-adjusted D-dimer. If D-dimer negative (< age × 10 ng/mL in >50y, or < 500 ng/mL otherwise) — PE excluded, no imaging needed. If positive — proceed to CTPA. Consider PERC rule first in low-pretest cohort.
Three-tier interpretation: Low (1.3%)
Cut CTPA over-utilisation in your ED
EasyClinic combines Wells + PERC + age-adjusted D-dimer logic in a single OPD workflow. Studies show 30% fewer unnecessary CTPAs when the algorithm is applied consistently — saving the patient ₹4,000–₹8,000 per avoided scan.
Also Known As
What is the Wells Score for PE?
The Wells Score for Pulmonary Embolism is the most widely used pre-test probability tool for suspected acute PE. It was derived by Wells et al. (2000) and validated in over 4,000 patients across multiple studies. The score drives the diagnostic algorithm: low-probability patients are worked up with D-dimer; high-probability patients go straight to CT pulmonary angiogram (CTPA).
The current ESC 2019 guideline endorses the two-tier interpretation (PE unlikely ≤ 4, PE likely > 4) as more discriminating than the original three-tier version.
Score Components
- Clinical signs/symptoms of DVT — 3 pts
- Alternative diagnosis less likely than PE — 3 pts
- Heart rate > 100 — 1.5 pts
- Immobilisation ≥ 3 days or surgery in past 4 weeks — 1.5 pts
- Previous PE/DVT — 1.5 pts
- Hemoptysis — 1 pt
- Active malignancy — 1 pt
Diagnostic Pathway (ESC 2019)
- Wells ≤ 4 (PE unlikely): Age-adjusted D-dimer. Negative → PE ruled out. Positive → CTPA.
- Wells > 4 (PE likely): Direct CTPA. Skip D-dimer.
- PERC rule (8 criteria, all negative + low gestalt) can rule out PE without D-dimer in very-low-pretest patients (< 15% pretest probability).
- Age-adjusted D-dimer: Cut-off = age × 10 ng/mL (in patients > 50 years). Increases specificity without losing sensitivity.
Treatment Pearls (AIIMS / ICMR)
- Initial anticoagulation: Enoxaparin 1 mg/kg SC BD (₹350/dose) or UFH (₹40/day) if renal failure/obesity/thrombolysis planned.
- Massive PE (haemodynamic instability): IV alteplase 100 mg over 2 hrs (~₹35,000) or tenecteplase weight-based.
- Long-term: Switch to oral DOAC — apixaban 10mg BD × 7d then 5mg BD (~₹3,500/month), or rivaroxaban 15mg BD × 21d then 20mg OD (~₹2,800/month). Warfarin (~₹50/month) if cost prohibitive but needs INR monitoring (target 2–3).
- Duration: Minimum 3 months. Indefinite if unprovoked or persistent risk factor.
Frequently Asked Questions
▸When should I use Wells vs Geneva score?
Both perform similarly. Wells is more widely taught in India and easier to remember. The revised Geneva score is fully objective (no subjective "alternative diagnosis less likely" criterion), making it preferred for research and some EDs.
▸Is age-adjusted D-dimer safe to use?
Yes. The ADJUST-PE study (JAMA 2014) validated age × 10 ng/mL cut-off in >50-year-olds without missing clinically significant PE at 3-month follow-up. It is endorsed by ESC 2019 and ACEP 2018.
▸D-dimer is elevated due to COVID, sepsis, surgery — what do I do?
D-dimer has poor specificity in inflammatory states. In these patients, skip D-dimer and go directly to CTPA if PE is clinically suspected — or use bedside compression ultrasound + echocardiography as alternatives.
▸How does Wells perform in pregnancy?
Wells has not been validated in pregnancy. Use the YEARS-pregnancy algorithm (Van der Pol et al. NEJM 2019) which combines 3 clinical items + pregnancy-adjusted D-dimer thresholds.
▸Can I start anticoagulation before CTPA?
Yes, if Wells > 4 (high probability) and bleeding risk is low, ESC 2019 recommends starting therapeutic anticoagulation while imaging is arranged. This reduces early mortality.
▸What about PE in patients with active TB or COVID-19 (common in India)?
Both increase VTE risk substantially. COVID-19 inpatients have 14–30% PE incidence. Maintain high suspicion. CTPA threshold should be lower in these populations.
References
- Wells PS et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism. Thromb Haemost 2000;83(3):416-20
- Konstantinides SV et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J 2020;41:543-603
- ACEP Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients With Suspected Acute Venous Thromboembolic Disease. Ann Emerg Med 2018
- Righini M et al. Age-adjusted D-dimer cutoff levels to rule out pulmonary embolism: the ADJUST-PE study. JAMA 2014;311(11):1117-24
- AIIMS Department of Medicine — Acute Pulmonary Embolism Protocol (2023)
Smart PE workups, integrated with your lab and radiology
EasyClinic flags Wells, PERC, age-adjusted D-dimer cut-offs, and Geneva score side-by-side. One click to order CTPA with the right contrast volume calculated for the patient's eGFR — and the pre-authorisation message drafts itself for insurance.
Trusted by Indian doctors who want to stop typing
Choose the plan that fits your practice — cancel anytime.
DOCTORSCRIBE
AI Medical Scribe
₹999
/month
- ✓ Voice → prescription in 30 seconds
- ✓ 11 Indian languages (Hindi, Tamil, Telugu, etc.)
- ✓ Auto pediatric dose by weight
- ✓ ICD-10 codes, drug interactions
EASYCLINIC
Complete Clinic Platform
₹1,999
/month
- ✓ Everything in DoctorScribe, plus:
- ✓ Patient records, billing, GST invoices
- ✓ WhatsApp reminders to patients
- ✓ Multi-doctor scheduling + analytics
- ✓ All 60+ calculators built into the chart